Share Name Share Symbol Market Type Share ISIN Share Description
Hutchison China Meditech LSE:HCM London Ordinary Share KYG4672N1016 ORD USD1
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +100.00p +1.94% 5,262.50p 5,225.00p 5,300.00p 5,280.00p 5,162.50p 5,162.50p 144,708 16:07:35
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 175.0 -38.3 16.2 347.7 3,196.98

Hutchison China Meditech Share Discussion Threads

Showing 1276 to 1300 of 1300 messages
Chat Pages: 52  51  50  49  48  47  46  45  44  43  42  41  Older
DateSubjectAuthorDiscuss
18/11/2017
08:19
I agree with steeplejack, the Company is bid proof because HHHL owns 60% and bought the majority of the recent placing. The Company's management and its largest holders know that the business will, over the next five to ten years, be worth many multiples of today's valuation. I could see a deal, whereby a Celgene, Gilead or Lilly buy rights to an unpartnered late stage drug such as Sulfatinib, but I doubt HHHL will be interested in a bid for a long time yet.....I hope. My most recent share price forecast was £53 by the time of the FY17 annual results announcement in Q1 next year, which was reached yesterday, based on a fairly complex model, it will be £250 per share by 2026 for anyone planning to still remain invested!
nerdofsteel
17/11/2017
16:32
I use Hargreaves lansdowne, no problem with US shares in ISA.
rabiddog
17/11/2017
14:54
Thanks learningtrader and kinkell.
reptile3
17/11/2017
14:21
Reptile3 Thanks for reply. Would expect most full service brokers to be able to accommodate such a change.
kinkell
17/11/2017
13:56
Repitle3 - you can hold foreign shares in your ISA, I certainly hold USA listed shares in my ISA like Visa, Nvidia and FB. Hope this helps
learningtrader
17/11/2017
13:22
kinkell..... Nerdofsteel has suggested the company may delist from AIM in the future and trade solely on the NASDAQ where most trading currently takes place. My concern is that AIM listed HCM shares held in an ISA would then be converted to ADS's and tradeable only on the NASDAQ. Questions arise as to whether my broker (or anyone else's) can handle the conversion and also provide a platform for trading on the NASDAQ. For example, I'm pretty sure Saga can't or wont do this. Then there is the question of whether an ISA can be applied to a share which is only traded in another country (the USA). I intend taking this up with my broker (TD Direct)and will post their reply if I get one.
reptile3
17/11/2017
13:01
I doubt any company is bid proof nowadays. But long may HCM stay independent rather than taken out in infancy, I only bought it at around GBP 42 per share. Looking forward to steady increases over time rather than one-off bid premium.
learningtrader
17/11/2017
11:54
This company is bid proof.
steeplejack
17/11/2017
10:37
Big trades but dwarfed by the amount traded in the US: the last couple of days have seen the equivalent of £20m worth of shares traded
mad foetus
17/11/2017
10:19
This looks like news ? 10:16 - 17/11 Buy 4880 5,300.00p £258,640.00 10:04 - 17/11 Buy 5000 5,300.00p £265,000.00
haydock
17/11/2017
09:50
I wonder whether Glaxo are thinking of a bid here? It has been something that has been raised in the past and they could do with a new pipeline desperately
mad foetus
17/11/2017
08:54
Reminds me of Glaxo which enjoyed a spectacular run from the early 80s to the end of the century.
steeplejack
16/11/2017
22:59
Indeed, agree 100% Chappy, personally I am holding and buying until 2026
nerdofsteel
16/11/2017
15:34
Just hold and watch it grow.
city chappy
16/11/2017
11:43
Decent volume, as anticipated. Narrow spread, which I hadn't expected: perhaps they are trying to encourage sellers out for institutional buyers?
mad foetus
16/11/2017
07:36
£50 today, meeting my end of year target.... £85 end 2018
nerdofsteel
16/11/2017
06:26
thanks nerd, thought he spoke very well and came across as very measured. you certainly got the feeling he wasnt someone who was ever going to promise things he could not deliver. good luck all, should break £50 today and plenty of news to come
mad foetus
16/11/2017
03:05
Vol / Avg. 323,341.00/86,111.00 final NASDAQ numbers for Tues 15th Nov There was a large amount of buying on NASDAQ, possibly prompted by the CEO's appearance on CNBC??? It certainly looks as if the Company's profile is being raised as more people and specialist investors take on board what the incredible prospects are.... If you consider we have just had a huge fundraising, far more than is needed for short to medium term pipeline development I believe some kind of mega deal is on the cards. Pure speculation but I think the Company's profile is about to be raised significantly!
nerdofsteel
15/11/2017
22:11
Reptile3 Why do you think de-listing from AIM would adversely impact your ISA protection?
kinkell
15/11/2017
22:10
Our CEO on CNBC today https://www.cnbc.com/video/2017/11/15/pchinese-biotechs-rise-on-the-global-pharma-scene.html
nerdofsteel
15/11/2017
21:14
YesWonderful on a down day
nfs
15/11/2017
20:23
Up 9% on massive volumes, over £50 tomorrow!
mad foetus
15/11/2017
16:06
Up again in US on much bigger volume than UK. I'm loving 2-3% each day!
mad foetus
15/11/2017
12:32
As an investor in the Slater growth fund today I have just received their factsheet dated 31st of October and that fund now has just over 11% in this stock very good news
montynj
14/11/2017
20:00
Another strong day stateside, around £48 on good volume, though volume always is these days over there.
mad foetus
Chat Pages: 52  51  50  49  48  47  46  45  44  43  42  41  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20171118 23:45:35